Vedolizumab treatment outcomes in early versus late Crohn's disease [0.03%]
vedolizumab治疗早期与晚期克罗恩病的效果
Rirong Chen,Kenneth Croitoru,Sun-Ho Lee
Rirong Chen
Vedolizumab treatment outcomes in early versus late Crohn's disease [0.03%]
vedolizumab治疗早期与晚期克罗恩病的效果差异
Nurulamin M Noor,Ailsa L Hart,James C Lee et al.
Nurulamin M Noor et al.
Antipruritic effects of the ileal bile acid transporter inhibitor linerixibat [0.03%]
胆汁酸转运体抑制剂linerixibat的止痒作用
Gideon M Hirschfield,Andreas E Kremer,Cynthia Levy
Gideon M Hirschfield
Viral hepatitis in Roma communities: vulnerabilities and improving care access [0.03%]
罗姆人社区的病毒性肝炎：脆弱性和改善护理访问途径
Pavol Kristian,Ivana Hockickova,Monika Halanova et al.
Pavol Kristian et al.
The Lancet Gastroenterology Hepatology
The Lancet Gastroenterology Hepatology
Global gains, metabolic pains: unmasking the hidden burden on liver health [0.03%]
全球收益与代谢痛苦：揭开肝脏健康的隐性负担
Maja Thiele,Ajeet Singh Bhadoria,Jessica Mellinger et al.
Maja Thiele et al.
Long-term oncological outcomes following algorithm-based care versus usual care for the early recognition and management of complications after pancreatic resection: a post-hoc analysis of a nationwide, stepped-wedge cluster-randomised trial [0.03%]
基于算法的胰腺切除术后早期并发症识别和处理与常规护理相比的长期肿瘤结局：一项全国范围分阶段嵌套群随机对照试验的事后分析
Thijs J Schouten,Kyra J Prinsze,Anne Claire Henry et al.
Thijs J Schouten et al.
Background: Studies have shown that severe postoperative complications after resection of pancreatic and periampullary cancer might have a negative effect on long-term oncological outcomes. The PORSCH trial showed that an...
Jillian Horton,Edward V Loftus Jr
Jillian Horton
Cyclic exclusive enteral nutrition: a novel approach to maintaining remission in paediatric Crohn's disease [0.03%]
儿童克罗恩病维持缓解的新型营养管理策略——周期性肠内营养法
Anissa M Armet,Eytan Wine
Anissa M Armet